ALDH2 based genetically tailored management following catheter ablation for atrial fibrillation

ALDH2 based genetically tailored management following catheter ablation for atrial fibrillation - AGENT-AF

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051130

Enrollment

350

Registered

2023-05-23

Start date

2023-06-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Patients with a drinking habit in ALDH2 wild type carriers who do not receive drinking guidance (period of 1 year). Patients with a drinking habit among ALDH2 wild type carriers who will receive drink

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing initial catheter ablation for atrial fibrillation at participating institutions.

Exclusion criteria

Exclusion criteria: Exclude definition is refuse of the target patient.

Design outcomes

Primary

Measure	Time frame
The difference in atrial fibrillation recurrence during one year follow up following catheter ablation between the group with and without alcohol control guidance. This investigation was performed in each ALDH2 gene.	—

Countries

Japan

Contacts

Public ContactTadashi Hoshiyama

Kumamoto University Cardiovascular medicine

tadashi@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026